Summary. Both mortality and morbidity data indicate quite clearly that multiple sclerosis is a geographically-related disease, and thus MS can be thought of as an acquired environmental (exogenous) illness. High frequency parts of the world for MS are Europe between 65 ° and 45 ° north latitude, northern United States and southern Canada, New Zealand, and southern Australia. These regions are bounded by medium frequency MS regions: in Europe to the north, east, and south; in America for southern U.S.; and the remainder of Australia. Latin America, Asia and Africa are essentially of low frequency from present data. Latitude is not a sufficient criterion: at 40 ° north latitude, MS is high in America, medium in Europe, and low in Asia.
Introduction
Multiple sclerosis (MS) is a demyelinating disease of young adults characterized by symptomatology which occurs over a considerable extent of time and often with exacerbations and remissions. There is no known cause for this disorder, and little in the way of effective treatment. Some of the more tantalizing clues to etiology have arisen from considerations of the natural history of MS--i.e., its epidemiology. And among these the most important have concerned the geographic distribution of the disease. It is safe to say that, whatever may ultimately be discovered as to the specific cause of MS, it will have to account for the epidemiologic aspects of the illness.
The basic material of epidemiology has to do with geographic distribution, which refers to frequency within specific locales for specific groups. The frequency of disease is best defined by relating the cases to the population from which they are drawn. The three commonly used measures to provide this information are incidence, mortality, and prevalence rates. The incidence or attack rate is the number of new cases of the disease beginning in a given period of time, usually one year, and divided by the population at risk. The mortality or death rate refers to deaths caused by the illness during a given period per unit of population, and again one year is usual. The prevalence rate represents the number of cases present at one time in the population. These rates may refer to the total cases and population, or be subdivided according to specific ages or sex for both cases and population.
Age-specific incidence rates for multiple sclerosis in Denmark reveal a sharp increase in adolescence, a plateau in young adult years, and a disappearance of new cases by age 60 (Kurtzke and Hamtoft, 1976) . The female rates are notably higher than the male in the younger ages. Age-specific prevalence rates from the same Danish series show a marked peak in the fifth decade, and almost all of the patients are age 20 to 70 at prevalence day (Hyllested, 1956) .
Geographic Distribution
There is a massive literature on the geographic distribution of multiple sclerosis, and no attempt whatsoever will be made to review either the specific material or its development. I will try to provide a bare minimum on death distributions, and as summary a statement as possible on the morbidity data. This though is the epidemiologic information which constitutes the basic "facts" on MS, upon which all hypotheses need be built. Further considerations may be found in reviews prepared for the 1973 Kyoto Symposium on Demyelinating Disease (Kurtzke, in press (a) ) and for the forthcoming book by E. J. Field, to whom I am greatly indebted for his permission to reproduce here a considerable portion of my chapter (Kurtzke, in press (b) ). The reader should be warned that what follows are my own interpretations of the available material, which eminent authorities have often considered in quite different lights. Among the outstanding workers who should be consulted for a perhaps more balanced view are Acheson (1972) , Leibowitz and Alter (1973) and Kurland (1970) .
Geography from Death Data
A very useful contribution was the paper by Goldberg and Kurland (1962) presenting death rates for a number of neurologic diseases for deaths within the 1951--1958 period. All the rates were age adjusted to the 1950 population of the United States, and referred to diseases coded as the underlying cause of death. These death rates from multiple sclerosis are drawn in Figure 1 from the data of Goldberg and Kurland, but reorganized according to geography.
The rates in most of western Europe are in the order of 2 per 100,000 per year or higher, although the northernmost lands are closer to 1 per 100,000, as are Canada, US whites, and New Zealand. Within Europe there seems also a sharp drop to the rates from the Mediterranean basin. South American rates would seem rather low, as are those for US nonwhites (of whom more than 90 per cent are Negro). The Asian and African rates are clearly the lowest recorded.
Geography from Prevalence Data
Before World War II, there were almost no proper prevalence surveys for MS. Since the war they have been burgeoning, and now number somewhere near 170. When first reviewed some years ago, it was my impression that the prevalence Fig. l . Average annual mortality rates per I00,000 population for multiple sclerosis from various countries within the 1951--1958 period, adjusted for age to the 1950 U. S. population. Redrawn from data of Goldberg and Kurland (1962) . From Kurtzke (in press (b)) rates for multiple sclerosis divided the world into three areas comprising high, medium, and low frequency regions (Kurtzke, 1964) . This impression was contrary to the prevailing opinion of a rather smooth relationship of MS frequency with geographic latitude.
Prevalence by Latitude. The prevalence studies now available for Western Europe are summarized in Figure 2 , as a correlation of the rates with north latitude. The numbers refer to specific surveys described elsewhere (Kurtzke, 1975a, b Kurtzke (1975a, b) . Solid circles represent Class A studies, open circles Class B, diamonds Class C, and squares Class E. Vertical bars define 95% confidence intervals of the rates. From representing proper surveys with well-defined and comparable methodology and diagnostic standards. Those I rated Class B (open circles) are good surveys but have reason(s) why they are not fully comparable to those of Class A. Surveys denoted by diamonds are Class C. These have obvious defects which make them likely to be unreliable, and they should not be taken at face value. Open boxes are Class E surveys, which represent an estimate of the prevalence from the ratios of MS to ALS cases in series from hospitals. Surveys numbered 1--9 are from the United Kingdom, 10--24a from Scandinavia, 25--30 from Germany, 32--40 from France, and 41--51a from Italy. Also represented are the Netherlands (No. 31), Spain (40a) and Switzerland (52).
It seems to me that MS in Western Europe is in fact distributed according to latitude within two bands: a high frequency zone with prevalence of some 30--80 per 100,000 population (or more) extending from about 43 ° to 65 ° north latitude; and a medium frequency zone with prevalence of some 5--25 per 100,000, and mostly 10--15, from about 38 ° to 46 ° . Similar data for Eastern Europe are drawn in Prevalence surveys from the Americas are denoted in Figure 4 . Here we see all three risk zones: high frequency from 370--52 ° , medium frequency from 30o--33 °, and low frequency (prevalence less than 5 per 100,000) from 12°--19 ° and from 63 ° --67 ° north latitude. The coterminous United States and southern Canada are represented by all the surveys from number 88 to 119a, except for numbers 106 (Greenland), 109 (Jamaica), 113 (Alaska), 117 (Netherland Antilles), and 118 (Mexico City).
Australia-New Zealand comprise a high frequency zone for 440--34 ° south latitude, and a medium frequency region for 33°--15 ° south (Fig. 5 ). The recorded rates though which are considered high are toward the lower end of this range. Rates from Asia and the Pacific in the northern hemisphere are all low, except that Hawaii (No. 145, 146 ) is likely to be in the medium zone (Fig. 6 ). These study sites extend from 8 ° to 47 ° north latitude. In the southern hemisphere, with surveys from 30 ° to 6 ° south, all rates from Asia and Africa are also low, except for English-speaking native-born whites of South Africa (No. 156), as seen in Figure 7 . Prevalence by Longitude and Latitude. While there seems to be then a reasonably clear separation into three zones of MS, latitude alone appears to be an insufficient criterion both in Europe and America. And in Asia and the Pacific, latitude seems not a factor at all. Figure 8 represents the rates in Europe by both latitude and longitude. Parallels of latitude, with open numbers, run diagonally upward from left to right, while meridians of longitude, with solid numbers, run diagonally downward. The prevalence surveys are designated by the same numbers and symbols as previously. The rates are measured by the height of the vertical bars, with the locus of each study at the foot of each bar. The areas of special interest are the grids between 50 ° and 40 ° north latitude and 0 ° and 20 ° east longitude. There is a sharp drop in MS prevalence within these grids, along an arc that extends from about 50 ° N, 20 ° E toward about 40 ° N, 0 ° E. To either side of this dividing line, most of the rates are of similar magnitude within their own region: high to the north and distinctly lower to the south.
We can therefore simplify the presentation considerably if we accept prevalence rates of 30--80 per 100,000 population (or more) as representing high frequency MS, those of 5--25 as medium frequency, and those under 5 per 100,000 as low frequency MS. We can further group the studies into "good"
(Class A, B, E) and "poor" surveys, the latter including not only Class C but also several relative frequencies (percentages) from hospitals within the USSR. In this (Fig. 9 ). More geographic orientation is provided by plotting the surveys for Europe directly on the map (Fig. 10) . Here solid squares represent all high frequency surveys regardless of quality, and open (actually shaded) squares represent all medium ones. The triangles reflect rates which may be medium or low, but are likely to be medium. The heavily shaded part of the map defines the high frequency MS zone of Europe, and the dotted portion defines the medium frequency MS band. Within the heavily shaded portion the dashed line may be the actual separation of high from medium risk areas, but the data are inconclusive (Kurtzke, 1975b) .
In the same fashion as in Figure 9 , we can decribe MS distribution in the Americas (Fig. 11 ) and from Asia (Fig. 12) . For the latter, the high-risk "band" is New Zealand, southern Australia--and ocean. To the top left is what may be the eastern limit of the Eurasian medium frequency zone. All other medium frequencies are from Australia, and the remainder of Asia is low.
The world-wide distribution of MS, so far as we now know it, is summarized then in Figure 13 . Note that latitude alone is really not a good measure of MS frequency. At 40 ° north, for example, MS is high in America, medium in Europe, and low in Asia.
Other Aspects of Geography
The division of the world into three risk areas for MS of itself provides few leads as to the nature of this illness, but further considerations of the distribution may take us another step or two. One aspect is the finer structure of the geographic distribution.
Clustering
When the entirety of a country is surveyed at a single time by a single team, then it is possible to describe the geographic distribution across the land in some detail. Such surveys have been accomplished for Norway, Denmark, Sweden, Switzerland, Northern Ireland, northern Scotland, The Netherlands, Iceland and Finland. Repeated surveys covering different generations of patients (and doctors) have been accomplished for Norway, Denmark and Switzerland.
While the distribution within Northern Ireland was uniform and that within the Netherlands and Iceland rather equivocal, in all other countries surveyed there were very highly significant deviations from homogeneity, and the high-rate areas tended to be contiguous, forming clusters or foci. The differences in the rates between the highest and lowest regions were in the order of six-fold on the average, and thus the variations would seem of biologic as well as statistical significance (Kurtzke, 1966 (Kurtzke, , 1967a . Essentially the same clusters were found when small geographic units rather than the large counties were used as the units for testing (Kurtzke, 1967b) . In Denmark the clustering was across middle Jutland on to Fyn, the island next to mid-Jutland; in Switzerland the concentra- . Each county rate is expressed as the percentage of its respective national (mean) rate. From Kurtzke (1974) tion was in the northwestern part of the country. The MS distributions were not related to availability of medical facilities, including hospitals, hospital beds and admissions, all physicians, or neural specialists (Kurtzke, 1965b) . Not only was there clustering of MS, but in the lands resurveyed a generation apart, there was a very strong correlation between the early and the later distributions, with correlation coefficients of about 0.8 (Kurtzke, 1969 (Kurtzke, , 1974 . In Figure 14 the rates by county from each survey are correlated for the three countries with such data: Denmark, Switzerland, and Norway.
With this evidence of stability over time, it was thought appropriate to compare studies from neighboring countries to determine whether any broader pattern might be apparent. In this fashion, the high frequency MS areas appeared to describe one single Fennoscandian focus (Kurtzke, 1968 (Kurtzke, , 1974 . With the smallest test-units available, this focus extended from the waist and southeastern mountain plains of Norway eastward across the inland lake area of southern Sweden, then across the Bay of Bothnia to southwestern Finland, and then back to Sweden in the region of Ume~ (Fig. 15) .
This clustering, as well as the broader geographic distributions already considered, mean to me that the occurrence of MS is intrinsically related to (1951--65) ; prevalence rates from hospital cases within 106 small units of Sweden (1925--34) ; disability prevalence rates within 20 hospital districts of Finland (1964) ; and childhood prevalence rates within 23 counties for the national series of Denmark (1949) . Fine horizontal shading represents lakes in Sweden and Finland. From Kurtzke (1974) geography, and therefore that MS is an acquired, exogenous, environmental disease. When and where it may be acquired may be considered from migration studies.
Migration
R e t u r n i n g to the b r o a d e r distribution of MS, the definition of regions .differing in risk provides the basis for inquiring into the fate of migrants a m o n g these regions. Table I summarizes material on prevalence rates (all ages) a m o n g immigrants to and from different M S risk areas (Kurtzke, 1972; Kurtzke and Kurland, 1973) . The rates are those regardless of age at immigration and of time of clinical onset of MS in reference to migration.
In b r o a d terms, the immigrants do tend to retain the M S risk of their birthplace. "Risk" is defined according to the same three frequency zones previously discussed. The evidence for risk retention is better for immigrants from high risk areas to low than is the reverse, where there are in fact very sparse data. The evidence is the least impressive for Australia, where the migrants a p p e a r to have appreciably lower rates than expected for their homelands. This t h o u g h is explicable by Australian immigration laws dealing with the disabled. Few of these M S migrants would be likely to have had clinical o n s e t --o r at least d i a g n o s i s --b e f o r e immigration. In the South African study to be discussed below, a b o u t half the E u r o p e a n immigrants were s y m p t o m a t i c before their move. Were this to apply to Australia, then the immigrant rates there could perhaps be doubled.
The Israeli d a t a should be considered from the age adjusted rates, since their several p o p u l a t i o n s have strikingly different age compositions. It may be that the A f r o -A s i a n immigrants (low risk) to Israel (medium risk) have an increased frequency over that of their birthplace, but it is really too early to be sure. Other data on low to high areas are sparse. Dassel (1972) recorded three instances of MS among immigrants from Indonesia to Holland. Their onsets were at ages 17, 23 and 25 years, and took place respectively 7, 9 and 8 years after their arrival in the Netherlands. They are probably whites of Dutch origin, but neither this nor the population at risk was provided. Regardless, three cases out of what is likely to be a small migrant group looks impressive.
We have discovered three instances of exacerbating-remitting MS among a series of some 3400 children who were born in Vietnam of Vietnamese mothers and French fathers, and who came to France under the age of 20. At interview in 1975, 80 percent were age 20--39. The three MS patients each had clinical onset about 15 years after immigration, which for them was under the age often. Their crude prevalence rate for MS was 89 per 100,000, with a 95 percent confidence interval of 18--260. Since the group is still at risk for MS, adjusting this rate for age would be misleading. The age-specific prevalence rate was 169 per 100,000 age 20--29 (confidence interval 35--494). It appears then that these half-Oriental Asians have a significantly higher rate than had they stayed home, but whether it is really as high as expected in France is unknowable at present (Kurtzke and Bui, in preparation) .
Contrary viewpoints as to migrants from low to high risk have been provided by Detels and by Dean, both of whom claim that individuals born in low-risk areas do not increase their risk of MS upon moving. Detels et al. (1972) recorded MS death rates for two states on the west coast of the United States (Table 2) . Here the small numbers of southern migrants show no significant difference when they move north, but the northern migrants to California have a significantly lower death rate than those who moved to Washington. Similar findings were presented for the prevalence of MS among migrants to the same states (Detels et al., 1976) . Again though the numbers of southern migrants were too few for confidence, in my opinion. Dean et al. (1976) , with a comparison of hospitalizations among immigrants and natives of London, recorded many fewer cases in the former than they expected from the latter. However, even if that were valid (and there are questions as to the appropriate expectations), it would not speak to the question (Table 3 ). The ratios for the United States are also the death rates, and the rate of 0.68 for the southern-born who died in northern US was significantly higher than the rate of 0.46 for those born and died in the south . Unpublished data from a large series of U. S. veterans with MS versus military controls also support the concept of an increased risk of MS among the southernborn who moved north before entry into service (Kurtzke, Beebe and Norman, in preparation) . The question of risk of MS in migrant populations gets quite involved, being dependent not only upon a sufficient number of migrants who change their residence from one risk area to another, but also upon their ages at prevalence day, their length of stay in the new land--and their age at migration. Tables 2 and 3 indicate quite clearly that birthplace alone is not the critical factor in the risk of MS. Were this the case, the migrants would have had the same rates as for their birthplace.
Age at Migration. The rates of
In Table 4 are case-control ratios for residences among a U. S. Army series of "definite + probable MS" (Beebe et al., 1967; Kurtzke et al., 1971) . The very clear difference in MS risk (as defined by the ratios) that was present for residence at birth or at entry into service had totally disappeared in the rather short interval between entry and clinical onset. The inference here then is that the critical age in risk of MS is well before onset and well before age 20 or so.
From ages of maximal clustering of MS in Denmark and several other features, it was "tentatively concluded that the actual onset of MS appears to take place on the average between the ages of 10 and 15 years, and that there is probably a "latent" or "incubation" period of some 20 years before the onset of clinical symptomatology" (Kurtzke, 1965a, p. 156) . Included in this assessment was an ingenious approach to the problem by Poskanzer and his colleagues (Schapira et al., 1963) . They considered that, for siblings both of whom had MS, any common exposure would likely have occurred while they were living together. The period of cohabitation before onset averaged almost 20 years, and the mean age of such c o m m o n exposure was 12 or 13 years of age, with a mean "incubation" period then of some 20 years. The mean minimal exposure time was 6 years to the first case and 16 years to the second (Kurtzke, 1965 a) . A b o u t all these means t h o u g h the range was considerable. A n d the conclusions were based on natives of high-risk lands.
In one study at least, we were able to define a very specific age that was critical for the risk of MS, and this concerned a survey of E u r o p e a n immigrants to South Africa (Dean and Kurtzke, 1971) . F o r such immigrants, the M S prevalence rate, adjusted to a p o p u l a t i o n of all ages, is provided in Table 5 according to age at i m m i g r a t i o n (Kurtzke et al., 1970) . F o r immigration under age 15 there is the same m e d i u m prevalence rate as for the native-born English-speaking South Africans (Dean, 1967) . But for all older age groups, the prevalence is about what one would expect from their high risk homelands. In this series then, age 15 was critical for t h e acquisition of M S a m o n g those who came from high risk areas.
Race and Color
As recently as 1970, there was for M S "uncertainty as to selection by race" (Kurland, 1970, p. 75 ) independent of geography. Within the A r m y series noted above, Negroes were a b o u t half as frequent a m o n g the M S as service-wide p r o p o r t i o n s would suggest, regardless of birthplace or induction residence (Beebe et al., 1967) . We have recently been investigating a much larger series of all U. S.
veterans. These cases we have matched with military controls (before they were sick). The full paper is still in preparation, but in Table 6 are case-control ratios for the major sex and race groups . There is a clear excess of females a m o n g the whites and a clear deficit of black males, regardless of a One Filipino control included bratios of cases to controls for those born in northern and middle states (N) or in southern states (S) geography. The ratios for black males are a b o u t the same as we had previously found with the much smaller sample and without matched controls.
Further detail on the "other" males, i.e. those who were neither white nor black, is provided in Table 7 . The apparent deficit for Mexican Americans (6/10) is more likely a reflection of geography t h a n of race. On the other hand, while the n u m b e r s are too small for confidence, they suggest a paucity of MS cases a m o n g Amerindians (3/8) and American Japanese (2/4)regardless of birthplace. The low ratios for all servicemen born outside the coterminous United States may reflect either race or geography, or both. To explore this further we looked at all foreign-born regardless of race (Table 8 ). In Latin America including Puerto Rico, there is no evident difference by race, but a significant deficit by geography.
In Hawaii the deficit is among Japanese (0/10) and perhaps the Polynesians (0/5), while the single white case has a single control. In the rest of the Orient there is a significant difference for Filipinos as well. Detel's group was unable to find a single case of MS among 12,000 JapaneseAmericans in Seattle, Washington, where the native white prevalence rate was 69 per 100,000. The 95 percent confidence limit on the rate of 0 would be 31 per 100,000. There were 8/84,000 Japanese-Americans born in Los Angeles for a crude prevalence of 10 per 100,000, significantly lower than the native white rate of 22 (Detels et al., 1975; Detels, personal communication) . Further, Detels found no cases of MS among 20,000 Japanese immigrants to Seattle or 4000 to Los Angeles.
Thus there is growing evidence for racial predilection in MS. Negroes in the United States have less than half the risk of whites, regardless of geography, and this may be true as well for Amerindians. Japanese from Japan, the continental US or Hawaii, and Filipinos from the Philippines are also relatively "immune," as would be the Bantu of South Africa. Therefore MS is the white man's burden.
Looking back on the geography, we may see that all high-risk areas for MS--and indeed all medium-risk areas as well--are in Europe or in European colonies (like the United States). It would seem then that MS is the Western European Disease, which has been spread to other parts of the world. "Further work is necessary to see if one can define better the nature and the timing of the spread from Europe to other lands. Unfortunately early information on MS frequency is largely anecdotal. There is some evidence, though, that the distribution of MS in the United States has changed in this century. There is also evidence that the clustering of MS seen in Scandinavia and Switzerland has become less pronounced over time, further suggesting diffusion of the disease (Kurtzke, 1974) . There is also the curious difference in risk between the two groups of native whites of South Africa that requires exploration, but that could indicate the establishment of MS as a reasonably common disorder in that land within the past few decades." (Kurtzke, 1975b, p. 153 ).
Comment
The prevailing opinion about MS for much of this century to the 1950's had been that MS was some sort of allergic--or hypersensitivity--or a u t o i m m u n e --disease. Thus a bevy of workers have dedicated their lives to EAE (experimental allergic encephalomyelitis). Very few neurologists then thought seriously about an infectious origin, and virologists thought not at all of the disease. The attention of virologists to MS has been the direct result of the epidemiologic studies. Whether this has been a step forward or back remains for the future, but I do believe that the evidence is persuasive that we are dealing with an acquired, exogenous, environmental disease, whose acquisition is long before clinical onset in the normal situation. For natives of high risk areas this acquisition seems to be at adolescence, and one's geographic locale thereafter irrelevant.
Explanations for this among migrants from high to low risk areas fall into two conflicting interpretations, aside from the postulate of some unknown protective factor in the low risk areas. They are: (a) moving to low risk areas before adolescence protects one from the disease because it is thereafter acquired as a subclinical illness in the low-risk areas; and (b) moving thus protects one because he is too young to have acquired it by then in his native land. The former demands the disease agent to be rife where it is clinically absent, and the analogy has been with paralytic vs. non-paralytic poliomyelitis. The latter requires the disease agent to be located in the same place whether it causes clinical or subclinical involvement.
It is principally to differentiate between these two major and opposite possibilities that we need definitive information on low to high migration. Were the first (the polio analogy) correct, then migrants from low to high would show no increase in the risk of MS, since they are already protected by having been exposed from birth. Unless one demands "constant exposure from birth to age X" in order to be protected, any move at age X must be free of increased risk of MS. While still far from being sufficient for full confidence, there is, I think, considerable evidence from the death data and modest evidence from the morbidity work that migrants moving from low to high risk areas do indeed increase their chances of having MS. Thus the polio analogy seems unlikely to me.
But the primary question remains, if MS is an acquired disease, is it toxin, deficiency, or infection? The epidemiologic evidence would be explained most s i m p l y by an infection. And with the advent of the "slow viruses," a model does exist for an infection persisting for years with little evidence in the neuraxis and with a long incubation. If this is an infection, there should be evidence it is a transmissible illness--in the laboratory or in the populace. The former is not at hand as this is written, though flurries of interest continue to arise as one agent or another is proposed.
In the population, one can take transmissibility as one explanation for what seems to me the dispersion of this disease from Europe; but this could hardly be thought definitive even if the diaspora is fact. Good evidence for transmissibility would be the description of epidemics of MS. While pockets of cases have been described occasionally, most either do not hold up, or the numbers are so small that chance cannot be rejected as their explanation. I am not speaking here to the clustering I noted above; this of itself--even if accepted--is hardly evidence for transmissibility, though certainly compatible with that idea.
I think though that we have encountered a genuine epidemic of MS. Hyllested and I have been studying MS in the Faeroes, that small group of formerly Danish islands lying between Norway and Iceland. A preliminary summary dealing with our 1974 survey has been published (Kurtzke and Hyllested, 1975) . Our later visit in 1975, and current investigations on five or six more deaths, may alter the findings somewhat, but the main outline still seems valid, I believe.
In essence, all of 21 native cases of MS now known to us as of 1975 to have occurred in the Faeroes had their clinical onset between 1943 and 1960, save one whose onset was in 1962 after four years in Denmark, and one with onset in 1970. The 19 "native" cases of 1943--60 to me comprise an epidemic, with a sudden appearance and a sudden disappearance of the disease.
As to a likely cause of the epidemic, the only unusual occurrence in the Faeroes in recent times that we could discover was their occupation in World War II by British forces for five years from April 1940. They numbered some 8000 men, or almost one Briton for every three Faeroese. Locations of the cases and the British stations on the islands during the war were identical for most of the MS, and direct social contact with the troops was admitted by most the patients or their survivors. If this holds up, I think we do have strong evidence that--at least on the Faeroes--MS is a transmissible disease. Further speculation would be premature, but I think this is a very exciting area for our continued investigations.
